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e-mail address: hkatan@kkesh.med.sa (H.M. Alkatan).Hind M. Alkatan, MD a,⇑; Dora Hamad Al-Harkan, MD b; Mohammed Al-Mutlaq, MD c; Azza Maktabi, MD a; Sahar M. Elkhamary, MD dAbstractAim: To study the prevalence, clinicopathological and radiological correlations of epithelial lacrimal gland tumors and compare
these with similar published literature. The study was also designed to look at the natural history of benign mixed tumors
(BMT) in regard to recurrence and malignant degeneration.
Methods: This was a retrospective study of all suspected epithelial tumors of the lacrimal gland surgically excised at King Khaled
Eye Specialist Hospital (KKESH) for the period: 1983–2008. Exclusion criteria included structural lesions (dacryops) and inflamma-
tory lesions. We included 26 cases of epithelial lacrimal gland tumors (from 24 patients). The histopathologic slides and the radio-
logic findings were reviewed. The corresponding demographic and clinical data were obtained by chart review using a data sheet.
Results: BMT accounted for 12/26 of the lesions while malignant lesions including adenoid cystic carcinoma (ACC) were more com-
mon (14/26). The mean age was 44.27 years (range 12–75). Commonest clinical presentation was proptosis. Median duration of
symptoms in the BMT cases was 30 months and 7 months in the ACC group. The 12 BMT cases were primary in 9 and recurrent
in 3 patients. The 11 ACC cases showed mostly cribriform pattern and low histopathologic grade. We had 2 cases of malignant
mixed tumor (MMT) one of which arising in a recurrent tumor. One case of primary mucoepidermoid carcinoma with histopatho-
logic grade 2 was noted. Radiologically, a well-defined appearance with bone remodeling was observed in BMT in contrast to inva-
sive appearance with destruction in malignant lesions.
Conclusion: Our series information indicated a different distribution of benign and malignant epithelial lesions with a slightly
higher rate of malignancy. BMT was the commonest benign tumor where recurrence was a squeal of incomplete surgical excision.
ACC was the commonest malignant tumor with shorter duration of symptoms and radiologic evidence of invasiveness that corre-
lated with the histopathologic features.
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Lacrimal gland tumors are considered one of the challeng-
ing types of tumor which are difficult to study because of
their rare incidence as they represent almost only 10% ofthe space occupying orbital lesions.1 They are generally di-
vided into 4 categories: inflammatory lesions, lymphomas,
metastatic cancer, and primary epithelial tumors. The most
common epithelial tumors are, in order of frequency, benign
mixed tumor (BMT) or pleomorphic adenoma (PA), adenoide:
al.com
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rare variants of carcinoma are also seen, such as mucoepider-
moid carcinoma. Some of the primary malignant epithelial tu-
mors may arise from a preexisting BMT through a malignant
transformation -the so called carcinoma ex pleomorphic
adenoma (Ca ex PA), pleomorphic adenocarcinoma, or
malignant mixed tumor (MMT) but most arise de novo.
Because of rarity of these epithelial lacrimal gland tumors,
most published articles describe single cases or small series,
and only few large series have been reported in the English-
language literature. The correlation of the histopathologic
and radiologic features to the clinical presentation is impor-
tant to diagnose different types of tumor and their behavior.
Another important point is that lacrimal gland tumors have
not been studied in detail before in our population. The
aim of our study is to identify the distribution of different his-
tologic types of primary epithelial lacrimal gland tumors in
our population and to correlate the clinical, histopathologic
and radiologic features of such tumors surgically treated at
our tertiary referral center.Methods
The clinical, histopathologic and radiologic data of all sus-
pected epithelial tumors of the lacrimal gland surgically ex-
cised at King Khaled Eye Specialist Hospital (KKESH) for the
period: 1983–2008 were included. A single pathologist
reviewed the histopathologic slides. A single radiologist also
reviewed the radiologic findings. The corresponding demo-
graphic information and clinical data were obtained by
reviewing the charts of all the cases included. A specially de-
signed Data Base Sheet was used to report all the previous
information for each case. The data collected were then
analyzed to calculate the prevalence of different types of
epithelial lacrimal gland tumors. The correlation of the histo-
pathologic and radiologic features to the clinical data was
highlighted. Special attention was then directed toward any
cases of recurrent pleomorphic adenoma to identify the pat-
tern and occurrence of malignant change in comparison to
other studies.
This study has been approved by the Human Ethics
Committee-Institutional Review Board (HEC-IRB) of our
institution.Table 1. Frequency of epithelial lacrimal gland tumors.
Histopathologic diagnosis Number of cases Percentage
BMT (pleomorphic adenoma) 12 46
Adenoid cystic carcinoma 11 42
Pleomorphic adenocarcinoma 2 8
Mucoepidermoid carcinoma 1 4
Total 26 100%Results
We have encountered a total of 28 excised lacrimal gland
lesions at KKESH pathology department over a period of
26 years excluding structural (such as dacryops) and
inflammatory conditions (such as Sjogren’s syndrome and
non-specific dacryoadenitis). 3 lymphocytic lesions were
identified through tissue diagnosis accounting for about
10% only for the lesions and these were not studied further.
The rest were all true epithelial lacrimal gland tumors, which
were the focus of our study. 26 epithelial tumors from 24 pa-
tients (since 2 patients had recurrent lesions over their period
of follow-up at our institute) have been included. The benign
category consisted all of BMT accounting for 12/26 of the
lesions. The overall malignant lesions including ACC were
more common accounting for more than half of the total
lesions 14/26. The distribution of these cases is shown in
Table 1 and Graph 1.The age ranged from 12 to 75 years with a mean of 44.27.
The mean age did not differ much between the BMT and
ACC groups. The lacrimal gland affected was on the right
side in 14 cases and on the left side in 12. The male to female
ratio was 15:11. The majority of the 24 patients were Saudis
with a ratio of 16–8 non-Saudis.
The duration of symptoms ranged from 1 to 180 months
with an average of 38.19 months and median of 15 months.
However when this was studied in benign and malignant
groups separately, the median duration in the BMT group
was 30 months, while it was shorter (7 months) in the ACC
group. The median duration of symptoms in the Ca ex PA
was 120 months. The commonest complaints were proptosis
and globe displacement in 88% of the cases each. The distri-
bution of the presenting symptoms according to the different
types of tumor is demonstrated in Graph 2. Upon examina-
tion, the commonest finding was proptosis in 21/26 cases
ranging from 1 to 10 mm on the affected side (median
4 mm) followed by a palpable visible mass in 19/26.
The gross pathologic examination showed intact pseudo-
capsule in 10. 70% of benign lesions showed this feature. In
contrast 89% (8/9) of the malignant tumors showed capsular
infiltration. The only benign case with no intact capsule and
an outer surface described, as ‘‘with bosselations’’ was a case
of recurrent BMT. (Fig. 1a and b). The histopathologic
findings of the BMT cases showed the presence of a pseudo-
capsule in all 12 cases (Fig. 1c), however the capsule was infil-
trated by tumor extension in 5. The epithelial component was
predominant (described as major or moderate component) in
5 cases only and consisted of tubular, cystic (ductal) or epi-
thelial clusters in order of frequency (Fig. 1d). The stromal
component was mostly myxomatous (6/12) followed by carti-
lagenous. (Fig. 1e and f). The least common type of stroma
observed was osteoid and myoepithelial in 1 case each.
The metaplasia of the epithelial component was mostly squa-
mous and mainly observed in recurrent BMT.
The 12 BMT cases were primary in 9 and recurrent in 3 pa-
tients. The period until recurrence is observed was: 3 years
following the initial surgery in one case where the previous
histopathologic examination showed capsular infiltration
indicating incomplete excision at our institute, 9 years in
one of the 2 remaining cases who had his initial primary sur-
gery elsewhere but reported as incomplete excision as well
and undetermined in the third case. Follow-up of 8/12 cases
was available with a mean of 90 months and no evidence of
further recurrence.
Of the 11 ACC cases, cribriform pattern was noted in 6,
evident by characteristic Alcian Blue staining (Fig. 2a,b), solid
pattern (often with palisading) in 4 lesions (Fig. 2c,d) and
tubular in 1. The histologic grade was mostly G2 (7/11) and
the rest were G3. In regard to tumor behavior, vascular inva-
sion was documented in 5/11; orbital soft tissue and/or mus-
cle invasion was also confirmed in 5/11. This was followed by
perineural invasion in 1 case only. The TNM classification
Graph 2. The presenting symptoms in each type of epithelial lacrimal gland tumors.
Graph 1. Frequency of 26 epithelial lacrimal gland tumors.
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in (3/11). The last 2 cases were classified as T4 A and T4 B.
Unfortunately more than half of our cases (6/11) were lost
to follow-up. The mean follow up period of the remaining 5
cases was 82 months and they were well and alive. These
cases were all classified as either T1 or T2.
We had 2 cases of MMT or pleomorphic adenocarcinoma.
One of these cases was arising in a recurrent tumor (the so
called carcinoma ex pleomorphic adenoma = Ca ex PA). This
case had the malignant change in a second recurrence
14 years following the last excision at our institute (noted as
incomplete excision). The histologic grade of the adenocarci-
noma was high in this case. The other patient showed low
grade malignant change (adenocarcinoma) arising in a pri-
mary tumor with no evidence of previous biopsy or excision.
The malignant component was infiltrative in nature. There-
fore was not considered carcinoma in situ. No follow-up
was available for any of these 2 cases.
We had a single case of mucoepidermoid carcinoma of the
lacrimal gland, which was arising ‘‘de novo’’ and was of low
grade histopathologically.
Radiologic data were available for a total of 15 cases
mainly in the form of computerized tomography (CT). The
bone remodeling or excavation was described in 6 cases (4
benign and 2 malignant) while destruction was noted in 3
cases only – all malignant including the case of Ca ex PA.
Other important features included encapsulation and evi-
dence of invasion as presented in Graph 3. Calcificationwas an additional finding in 3 BMT cases. Invasion was further
documented by radiologic examination in 3 cases of ACC.Discussion
Out of all the lacrimal gland lesions, epithelial tumors ac-
count for only 20–30% while inflammatory and lymphocytic
lesions account for the remaining 70–80%.1,2 Among the re-
ported epithelial lesions, Shields et al. in 2004 concluded that
approximately 55% are benign and 45% are malignant.2 Their
conclusion was based on a comprehensive literature review
on the subject. This prevalence however might not be appli-
cable to various populations. Perez and his co-investigators
reported the clinicopathologic features of 18 epithelial lacri-
mal gland tumors in a single institution in Brazil over a period
of 36 years. 66.7% were ACC, 27.8% pleomorphic adenoma
and 5.5% carcinoma ex pleomorphic adenoma.5 This indi-
cates a different distribution of benign and malignant epithe-
lial lesions with a higher rate of malignancy. On the other
hand, studies in India demonstrated a distribution of benign
and malignant tumors of the lacrimal gland similar to what
was known in the old literature.3 The authors included all
the surgically excised lacrimal gland lesions over a 10 year
period. The distribution of benign and malignant lesions
was 51% and 42%, respectively. Their benign lesions have in-
cluded 1 lacrimal gland cyst. They had additional 3 cases of
pseudotumor and 1 case of sarcoidosis listed as other tumors
Figure 1. (a) Gross photo of a case of recurrent BMT with irregular outer surface, described as ‘‘with bosselations’’; (b) The corresponding
histopathologic appearance of the recurrent tumor with mixture of stromal and epithelial components. (Original magnification 100. Hematoxylin and
Eosin); (c) microscopic appearance of an intact capsule (red arrow) in a primary BMT. (Original magnification 100. Hematoxylin and Eosin); (d) the
epithelial component in another BMT forming several ducts (black arrows) within myxoid stroma. (Original magnification 100. Hematoxylin and Eosin);
(e) Microscopic appearance of the commonest classic myxoid stroma in BMT. (Original magnification 200. Hematoxylin and Eosin); (f) chondroid-like
stroma in a case of BMT. (Original magnification 200. Hematoxylin and Eosin).
Figure 2. (a) A case of ACC with cribriform pattern. (Original magnification 100. Hematoxylin and Eosin); (b) the same case with highlighted cribriform
pattern stained with Alcian-Blue. (Original magnification 200); (c) another ACC with solid pattern. (Original magnification 200. Hematoxylin and
Eosin); (d) a different ACC case of the solid type but showing evidence of palisading. (Original magnification 200. Periodic acid Schiff).
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Graph 3. Variable radiologic findings among benign versus malignant
lesions.
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lesions were benign epithelial in origin mostly being
pleomorphic adenoma.6 Shields et al. also concluded that
among benign lesions the most common were pleomorphic
adenomas and dacryops, whereas among the malignant
lesions ACC was the most common (66%), followed by
carcinoma ex pleomorphic adenoma (18%), primary adeno-
carcinoma (9%) and mucoepidermoid carcinoma (3%).2
The distribution of our epithelial lacrimal gland tumors
might indicate higher frequency of malignant lesions
(14/26) similar to what has been found by Danyel.5 However,
BMT was the commonest (46%) if ACC was compared to
other tumors individually (42%). This was also reported in a
larger series where BMT constituted 48% and ACC ac-
counted for 32% out of all tumors.10 Also the commonest
benign tumor was still BMT as shown in other series.1–7
Similarly ACC remained the commonest among the malig-
nant lesions.6,8 In regard to the histological classification of
our 26 lesions, rare tumors (except for our single case of
mucoepidermoid carcinoma) were not observed.10 It is worth
mentioning that our technique in the pathological grading of
all these epithelial tumors followed the recommendation by
Rootman and White.11
Demographics in our series showed wide age range (12–
75 years). The youngest patient had BMT. The mean age
was similar in both benign and malignant tumor groups being
43.82 in the first and 43.35 in the second. On the other hand
the mean age for the pleomorphic adenocarcinoma was old-
er (47 years). Others have also observed a wide age
range.6,10 There was slight male predominance similar to
what has been reported by Agarwal.6 Shields and their group
have suggested that ACC is slightly more common in women
but no overall general predilection for race or sex.2 This was
also observed in our cases with F:M = 7:4 in the ACC group
only.
Clinically, Graph 2 reflects the distribution of symptoms
among different categories according to diagnosis showed
that pain or tenderness was more common in ACC compared
to BMT possibly owing to their aggressive behavior.2,5 The
duration of symptoms had wide range however the median
for BMT was 30 months and much shorter (less than a year)
for ACC which was expected.4,5 The median duration of
symptoms for pleomorphic adenocarcinoma was 120 months.The eye on the affected side was found proptotic in almost all
the cases (benign and malignant) by clinical examination
(Fig. 3a and b). A palpable mass was another common finding
however motility problems and diplopia in our series were
not as common as expected even in the malignant category.2,5BMT
Pleomorphic adenoma remains the most common benign
epithelial tumor being extensively studied to allow reaching
the correct diagnosis and minimizing the risk of local
recurrence.5 The findings in our limited series clearly showed
that incomplete excision (evidenced by capsular infiltration)
was a major problem and a presumed cause for recurrence
of BMT as seen in 3 recurrent cases of our BMT. This was
noted especially in patients who had their primary surgery
elsewhere. On the other hand, cases operated in our institute
showed complete excision and resolved symptoms and signs.
(Fig. 3c and d)
Our BMT had mostly predominance of the stromal compo-
nent, which was myxomatous in most of the cases. Other
stromal components described in literature such as cartilag-
enous or osteoid were also observed. Squamous metaplasia
of the epithelial component was mainly observed in the
recurrent cases.
The malignant degeneration that can occur with BMT is
another unique and important feature mainly occurring in
recurring tumors following inadequate excision. Therefore,
careful surgical excision and good pathological examination
of such specimens were mandatory to document capsular
infiltration as in one of our cases.11 The findings in our limited
series clearly showed that incomplete excision (probably by
non experienced surgeons) in other institutions was a major
problem for recurrence of PA as seen in 4 recurrent cases,
3 of which recurring as BMT. The range of time interval be-
tween primary tumor diagnosis and removal of the recurrent
tumor was wide: 3 to 14 years with a median of 6.5 years.Recurrent BMT/MMT
It has been known that the recurrence of BMT carries the
risk of malignant degeneration5,10,12,13 however out of the to-
tal 4 recurrent cases in our series, 1 only was found to be
malignant occurring 14 years after the second recurrence. It
is worth mentioning that the first recurrence of this tumor
had shown focal areas of atypia (Fig. 4a,b) however not en-
ough to warrant the diagnosis of an adenocarcinoma.10,11
This malignant change (Fig. 4c and d) presented with a long
history of 23 years (9 + 14) after the primary lesion since it
was considered to be a second recurrence. Shield’s has
reported such a transformation in a case even after longer
period of 60 years.14 The other case of MMT was not recur-
rent (pleomorphic adenocarcinoma).
In regard to the histological classification of these cases,
Rootman and his co-authors stressed on differentiating
circumscribed carcinoma within a pleomorphic adenoma
‘‘Carcinoma in situ’’ versus an invasive carcinoma originating
from pleomorphic adenoma.7,11 The sub classification of such
cases included noninvasive, intracapsular or carcinoma
‘‘in situ’’/minimally invasive and noninvasive depending on
the extent of invasion from the capsule.1 Our recurrent case
was classified as invasive, showing high histologic grade of
Figure 3. (a and b) The preoperative clinical appearance of left eye proptosis in one of the cases in the benign group (BMT); (c and d) the postoperative
clinical appearance of the same patient with completely resolved left eye proptosis.
Figure 4. (a) Histologic appearance of first recurrence of the BMT. (Original magnification 100. Hematoxylin and Eosin); (b) the same BMT first
recurrence showing focal atypia (Original magnification 400. Hematoxylin and Eosin); (c) Ca ex PA malignant cystic areas of the second recurrence in
the same patient. (Original magnification 40. Hematoxylin and Eosin); (d) Ca ex PA showing capsular infiltration (Original magnification 100.
Hematoxylin and Eosin); (e) Ca ex PA showing bone invasion (Original magnification 100. Hematoxylin and Eosin); (f) Ca x PA showing perivascular
invasion (Original magnification 200. Hematoxylin and Eosin).
54 H.M. Alkatan et al.adenocarcinoma and with evidence of perivascular and bone
invasion (Fig. 4e and f).
The radiologic features of repeated CT films over 1 year of
follow up correlated with the clinical suspicious of malignantdegeneration in this case. (Fig. 5a–d). The second case of
pleomorphic adenocarcinoma was not recurrent, the patient
presented with significant proptosis and globe displacement.
Microscopic examination of the tumor showed low histologic
Epithelial lacrimal gland tumors: A comprehensive clinicopathologic and radiologic review 55grade of adenocarcinoma (Fig. 6a–d). Unfortunately no long
follow up periods were available for any of these 2 cases.
ACC
Out of the malignant tumors, the commonest was ACC,
which has a high frequency of recurrence.4,6,8 This tumor of
the lacrimal gland shared with its salivary counterpart, some
cardinal biologic features of indolence, persistance, metasta-
sis and death.7 ACC might present an advanced tumor with
bone invasion.5 Graph 2 representing the distribution of the
symptoms among different categories according to diagno-
sis showed that pain or tenderness was more common in
ACC compared to BMT possibly owing to their aggressive
behavior.2,7
In our cases, the cribriform pattern was the most common
morphologically (6/11) followed by the solid or basaloid (of-
ten with palisading) in 4/11 which was different than what
has been observed by others where the solid pattern was
much less commonly encountered.7,10
The chance of second recurrence in such a tumor was re-
ported to be 46% with a mean interval of 9.7 months fromFigure 5. (a) Initial CT scan of the patient at the time of his first recurrence in 1
homogeneously enhancing mass lesion involving the right lacrimal gland with m
enhancing Axial CT scans with second recurrence in 2002; (c and d) follow up
tissue mass with heterogeneous enhancement combined with aggressiveness
Figure 6. (a and b) The clinical presentation in a case of primary pleomorp
displacement; (c) pleomorphic adenocarcinoma primary (microscopic appe
capsular infiltration in the same case (Original magnification 400. Hematoxyexcision.8 The limited follow up in our ACC cases (5 patients
with mean period of 82 months) indicated favorable out-
come, as they were all well and alive with no evidence of
metastasis or recurrence. Our ACC cases however were all
classified as either T1 or T2, which might have affected the
prognosis in these patients.Mucoepidermoid carcinoma
We have encountered a single case of this rare malignant
epithelial tumor of the lacrimal gland. The grading of muco-
epidermoid carcinomas is usually according to the degree of
differentiation and relative number of mucin producing cells
where lower grades have more mucin cells. The classification
includes: grades 1–3 based on: cellularity, hyperchromatism
and frequency of mitotic figures. The most important prog-
nostic factor is the histologic grade. Our case was graded
histopathologically as grade 2. (Fig. 7a–d). Our case did not
seem to be arising from a preexisting PA in contrary to the
cases studied by Rootman and White.7 The excision was com-
plete in our case, with resolved postoperative symptoms989 which was 9 years following primary BMT excision elsewhere showed
olded appearance and rounded border; (b) Follow-up sequential contrast
CT in 2003, 14 years post an incomplete resection showing irregular soft
of the recurrent, malignant mixed tumor (double head arrow).
hic adenocarcinoma with more profound left eye proptosis and globe
arance). (Original magnification 200. Hematoxylin and Eosin); (d) the
lin and Eosin).
Figure 7. (a) Mucoepidermoid carcinoma appearance with low grade histopathologic features. (Original magnification 200. Hematoxylin and Eosin);
(b) the same tumor appearance with Periodic acid Schiff stain. (Original magnification 100); (c) Mucicarmine positive tumor areas (Original magnification
100); (d) mucin producing cell in the tumor (Original magnification 400. Alcian Blue); (e and f) the preoperative appearance of the patient with
mucoepidermoid carcinoma (right lacrimal gland); (g and h) the postoperative appearance of the same patient with resolved proptosis after complete
removal of the tumor.
56 H.M. Alkatan et al.(Figs. 7e–h) however, no long-term follow up was available
for this patient.Figure 8. CT scan of a case of BMT showing well-defined mass in the area
of the lacrimal gland (blue curved lines).Radiology
CT and MRI are utilized to differentiate between different
types of lacrimal gland masses and to determine the extent
of lesions involving the lacrimal fossa. Although many dis-
eases that affect the lacrimal gland are specifically diagnosed
by imaging, it is sometimes very difficult to differentiate each
specific disease on the basis of image characteristics alone,
however radiologic studies can still aid physicians in their dif-
ferential diagnoses.9 Recently, addition of Diffusion weighted
MRI sequence (DWI) and Apparent diffusion coefficient
(ADC) measurement coupled with MRI technique had en-
abled effective characterization of pathological features of
lacrimal gland lesions that might help in the early detection
of malignant lesions.15 Owing to the relatively long history,
benign lesions in our series showed bone remodeling or
excavation in addition to a well-delineated mass.1,6,9 (Fig. 8)
In contrast, ACC showed bone invasion and destruction.5The mucoepidermoid carcinoma case was studied by
Magnetic Resonance Imaging (MRI) and showed non-homog-
enous mass, cystic in nature with poor contrast enhancement
with hemorrhagic changes (Fig. 9a–c) This case had an intact
Figure 9. MRI photos in the case with mucoepidermoid carcinoma: (A–C) coronal T1 WI, Axial T2 with fat suppression and post contrast axial T1 with fat
suppression showed poorly enhancing bi-lobulated right lacrimal gland mass (black arrow) with hemorrhage (white arrow).
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cles within the capsule and no evidence of invasion histolog-
ically and radiologically.
Our radiologic findings aided in the clinical diagnosis and
had correlated well with the histopathologic characteristics in
general in our series.
Conclusion
We have observed that we tend to have higher number of
malignant epithelial lacrimal gland tumors with a ratio of
14:12. The commonest benign tumor was BMT or PA, while
the commonest malignant tumor was ACC. We had an over-
all male predominance, however ACC in our series showed
female predominance. The mean age and the clinical symp-
toms were similar in both benign and malignant groups.
Recurrence of PA was a major problem which seemed to
be related to incomplete surgical excision. Risk of malignant
change in our recurrent cases was relatively low. None of our
ACC cases with available follow up showed evidence of met-
astatic disease or recurrence. Radiology could aid in the diag-
nosis of cases and in differentiating between benign and
malignant lesions.
These observations would encourage further detailed
studies on the management and prognosis of these tumors.
The information would also be considered as baseline diag-
nostic information for future studies on cytogenetic charac-
teristics of epithelial lacrimal gland tumors in our population.
Conflict of interest
The authors declared that there is no conflict of interest.
References
1. Bernardini FP, Devoto MH, Croxatto JO. Epithelial tumors of the
lacrimal gland: an update. Curr Opin Ophthalmol 2008;19:409–13.2. Shields JA, Shields CL, Scartozzi R. Survey of 1264 patients with
orbital tumors and simulating lesions: the 2002 mongometry lecture,
part 1. Ophthalmology 2004;111:997–1008.
3. Zimmerman LE, Sanders TE, Ackerman LV. Epithelial tumors of the
lacrimal gland: prognostic and therapeutic significance of histologic
types. Int Ophthalmol Clin 1962;2(2):337–67.
4. Sanders TE, Ackerman LV, Zimmerman LE. Epithelial tumors of the
lacrimal gland. A comparison of the pathologic and clinical behavior
with those of the salivary gland. Am J Surg 1962;104:657–65.
5. Perez DEC, Pires FR, Almeida OP, Kowalski LP. Epithelial lacrimal
gland tumors: clinicopathological study of 18 cases. Otolaryngol
Head Neck Surg 2006;134:321–5.
6. Agarwal KR, Verma M, Menon S, Kumar K, Biswas J, Subramaniam N,
et al. Profile of lacrimal gland lesions at a tertiary care centre. All India
Ophthalmol Soc Proc 2006;389–91.
7. Rootman J, White VA, Alkatan H. Tumors of the lacrimal gland. 2nd
ed. Diseases of the orbit-a multidisciplinary
approach. Philadelphia: Lippincott Williams and Wilkins; 2003. p.
343–61.
8. Ramon LF, Shannon LS, Richard GB. Malignant epithelial tumors of
the lacrimal gland: a clinicopathologic study of 21 cases. Arch
Ophthalmol 1998;116:613–6.
9. Jung WS, Ahn KJ, Park MR, et al. The radiological spectrum of orbital
pathologies that involve the lacrimal gland and the lacrimal gland
fossa. Korean J Radiol 2007;8:336–42.
10. Weis E, Rootman J, Joly JT, Alkatan HM, et al. Epithelial lacrimal
gland tumors. Pathologic classification and current understanding.
Arch Ophthalmol 2009;127(8):1016–28.
11. Rootman J, White VA. Changes in the 7th edition of the AJCC TNM
classification and recommendations for pathologic analysis of
lacrimal gland tumors. Arch Ophthalmol Lab Med
2009;133:1268–71.
12. Riley FC, Henderson JW. Report of a case of malignant
transformation in benign mixed tumor of the lacrimal gland. Am J
Ophthalmol 1970;70:767–70.
13. Henderson JW, Farrow GM. Primary malignant mixed tumors of the
lacrimal gland. Ophthalmology 1980;87:466–75.
14. Shields JA, Shields CL. Malignant transformation of presumed
pleomorphic adenoma of lacrimal gland after 60 years. Arch
Ophthalmol 1987;105:2403–5.
15. El-khamary SM. Lacrimal gland lesions: can addition of diffusion-
weighted MR imaging improve diagnostic accuracy in
characterization? Egypt J Radiol Nucl Med 2012;43(2):165–72.
